Stathmin expression predicts response to taxanes in metastatic endometrial cancer

被引：1
|
作者：
Werner, Henrica M. J. [1 ]
Trovik, Jone [1 ]
Wik, Elisabeth [1 ]
Akslen, Lars A. [2 ]
Salvesen, Helga B. [1 ]
机构：
[1] Univ Bergen, Bergen, Norway
[2] Gade Inst, Bergen, Norway
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3158
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Stathmin expression in metastatic colorectal cancer
    Leiphrakpam, Premila D.
    Lazenby, Audrey J.
    Smith, Lynette M.
    Brattain, Michael G.
    Are, Chandrakanth
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (08) : 1764 - 1772
  • [2] Stathmin expression in endometrial hyperplasia: A potential marker for cancer progression
    Dickson, E.
    Ricketts, W.
    Jonson, A.
    Judson, P.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S4 - S5
  • [3] Endometrial cancer antitumor response with combination Wnt inhibition and taxanes
    Corr, Bradley
    Moroney, Marisa
    Woodruff, Elizabeth
    Wolsky, Rebecca
    Bitler, Benjamin
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S144 - S144
  • [4] Stathmin over-expression correlates with poor prognosis in patients with endometrial cancer
    Reyes, H. D.
    Bosquet, J. G.
    Stephan, J. M.
    McDonald, M. E.
    Leslie, K. K.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 66 - 66
  • [5] Gemcitabine and taxanes in metastatic breast cancer
    Amadori, D.
    Cecconetto, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V173 - V176
  • [6] Taxanes for the Treatment of Metastatic Breast Cancer
    Gradishar, W. J.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2012, 6 : 159 - 171
  • [7] Laboratory test predicts response of endometrial cancer to chemotherapy
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 871 - 871
  • [8] Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
    Werner, Henrica M. J.
    Trovik, Jone
    Halle, Mari K.
    Wik, Elisabeth
    Akslen, Lars A.
    Birkeland, Even
    Bredholt, Therese
    Tangen, Ingvild L.
    Krakstad, Camilla
    Salvesen, Helga B.
    PLOS ONE, 2014, 9 (02):
  • [9] SIGNIFICANT DECREASE OF PROGESTERONE RECEPTOR EXPRESSION PREDICTS RESPONSE TO MEGESTROL ACETATE IN PATIENTS WITH ENDOMETRIAL ATYPIAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Guan, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1077 - 1077
  • [10] Methylated PLK2 predicts response to taxanes
    Coley, Helen M.
    Chivers, Pritlata
    Syed, Nelofer
    Crook, Tim
    CANCER RESEARCH, 2012, 72
12345